Gene · 2195
Papers4,590
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,590
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epstein-Barr virus infection upregulates extracellular OLFM4 to activate YAP signaling during gastric cancer progression. | Nat Commun | 2024 | 39627192 | PubTator, text mining | PubMed |
| [Expression and clinical significance of FAT1 gene in pancreatic adenocarcinoma]. | Zhonghua Zhong Liu Za Zhi | 2024 | 39622735 | PubTator, text mining | PubMed |
| The Impoverished Publicness of Algorithmic Decision Making. | Oxf J Leg Stud | 2024 | 39619426 | PubTator, text mining | PubMed |
| Asymmetry of the Frontal Aslant Tract and Development of Supplementary Motor Area Syndrome. | Cancers (Basel) | 2024 | 39594695 | PubTator, text mining | PubMed |
| A Nondestructive Detection Method for the Muti-Quality Attributes of Oats Using Near-Infrared Spectroscopy. | Foods | 2024 | 39593977 | PubTator, text mining | PubMed |
| Genetic heterogeneity in familial forms of genetic generalized epilepsy: from mono- to oligogenism. | Hum Genomics | 2024 | 39574152 | PubTator, text mining | PubMed |
| Mutations of ARID1B, PIK3C2B, KMT2B, and FAT1 genes influence clinical outcome in newly diagnosed myeloma. | Cancer Genet | 2024 | 39536425 | PubTator, text mining | PubMed |
| Contributions of the Dachsous intracellular domain to Dachsous-Fat signaling. | Development | 2024 | 39503213 | PubTator, text mining | PubMed |
| Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma. | Br J Cancer | 2024 | 39478125 | PubTator, text mining | PubMed |
| Availability of residents and preceptors for interprofessional practices: mixed methods study. | Rev Lat Am Enfermagem | 2024 | 39476143 | PubTator, text mining | PubMed |
| Comparing mechanical and enzymatic isolation procedures to isolate adipose-derived stromal vascular fraction: A systematic review. | Wound Repair Regen | 2024 | 39444305 | PubTator, text mining | PubMed |
| Whole‑exome sequencing insights into synchronous bilateral breast cancer with discordant molecular subtypes. | Oncol Lett | 2024 | 39430730 | PubTator, text mining | PubMed |
| Hallmarks of a genomically distinct subclass of head and neck cancer. | Nat Commun | 2024 | 39428388 | PubTator, text mining | PubMed |
| Predictors of response to CDK4/6i retrial after prior CDK4/6i failure in ER+ metastatic breast cancer. | NPJ Breast Cancer | 2024 | 39424631 | PubTator, text mining | PubMed |
| Efficacy of Food Industry By-Product β-Glucan/Chitin-Chitosan on Lipid Profile of Overweight and Obese Individuals: Sustainability and Nutraceuticals. | Nutrients | 2024 | 39408385 | PubTator, text mining | PubMed |
| Mitochondria-targeted hydrogen sulfide donor reduces atherogenesis by changing macrophage phenotypes and increasing UCP1 expression in vascular smooth muscle cells. | Biomed Pharmacother | 2024 | 39405912 | PubTator, text mining | PubMed |
| Gene therapy for fat-1 prevents obesity-induced metabolic dysfunction, cellular senescence, and osteoarthritis. | Proc Natl Acad Sci U S A | 2024 | 39401356 | PubTator, text mining | PubMed |
| Identification of key genes and pathways involved in T-DM1-resistance in OE-19 esophageal cancer cells through bioinformatics analysis. | Heliyon | 2024 | 39309859 | PubTator, text mining | PubMed |
| Fat-Dachsous planar polarity function requires two distinct heterophilic cadherin-cadherin binding interactions. | Cell Rep | 2024 | 39302834 | PubTator, text mining | PubMed |
| Free-Running Cardiac and Respiratory Motion-Resolved Imaging: A Paradigm Shift for Managing Motion in Cardiac MRI? | Diagnostics (Basel) | 2024 | 39272732 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2195/papers?page=16